Phibro Animal Health (PAHC) Current Assets (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Current Assets came in at $894.1 million in Q1 2026, up 15.21% year-on-year from $776.0 million in Q1 2025, and up 3.7% quarter-over-quarter from $862.2 million in Q4 2025.
Phibro Animal Health (PAHC) Current Assets (2013 - 2026) Analysis & Trends
Phibro Animal Health's Current Assets history runs 14 years deep, the most recent figure standing at $894.1 million for Q1 2026.
- On a quarterly basis, Current Assets rose 15.21% year-over-year to $894.1 million in Q1 2026; TTM through Mar 2026 was $894.1 million, a 15.21% increase from a year earlier, with the FY2025 full-year figure at $810.6 million, up 34.88% from the prior year.
- Current Assets rose to $894.1 million in Q1 2026 per PAHC's latest filing, from $862.2 million in the prior quarter.
- Across five years, Current Assets topped out at $894.1 million in Q1 2026 and bottomed at $546.5 million in Q1 2022.
- The 5-year median for Current Assets is $586.6 million (2023), against an average of $664.7 million.
- Across the five-year window, Current Assets dropped 2.34% in 2024 and jumped 46.43% in 2025, its largest moves.
- Year by year, Current Assets stood at $581.7 million in 2022, then grew by 0.84% to $586.6 million in 2023, then rose by 27.2% to $746.2 million in 2024, then increased by 15.55% to $862.2 million in 2025, then rose by 3.7% to $894.1 million in 2026.
- Per Business Quant, the three latest PAHC Current Assets figures stand at $894.1 million (Q1 2026), $862.2 million (Q4 2025), and $835.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 894.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 894.07 Mn |
| Dec 31, 2025 | 862.19 Mn |
| Sep 30, 2025 | 835.80 Mn |
| Jun 30, 2025 | 810.61 Mn |
| Mar 31, 2025 | 776.02 Mn |
| Dec 31, 2024 | 746.15 Mn |
| Sep 30, 2024 | 570.77 Mn |
| Jun 30, 2024 | 601.00 Mn |
| Mar 31, 2024 | 597.18 Mn |
| Dec 31, 2023 | 586.59 Mn |
| Sep 30, 2023 | 584.42 Mn |
| Jun 30, 2023 | 585.72 Mn |
| Mar 31, 2023 | 585.48 Mn |
| Dec 31, 2022 | 581.69 Mn |
| Sep 30, 2022 | 570.08 Mn |
| Jun 30, 2022 | 566.23 Mn |
| Mar 31, 2022 | 546.48 Mn |
| Dec 31, 2021 | 508.61 Mn |
| Sep 30, 2021 | 498.63 Mn |
| Jun 30, 2021 | 498.91 Mn |